Week 2 '25-26 Mon 10/27-Sun 11/2 | |||||||||
| Team | Coach Rating | M | T | W | T | F | S | S | Total |
|---|---|---|---|---|---|---|---|---|---|
| (10-3) | 215 | 122 | 314 | 134 | 241 | 241 | 196 | 1,463.5 | |
| (3-10) | 247 | 170 | 195 | 195 | 190 | 193 | 191 | 1,380.5 | |
| Final Regular Season Game | |||||||||
| Name | Opp | Pts | Reb | Ast | Stl | Blk | Day | Total | Pos | Total | Day | Blk | Stl | Ast | Reb | Pts | Opp | Name | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G BOS | 19 | 5 | 4 | 1 | 0 | 37.5 | 120.75 | PG | 69.5 | 9 | 1 | 0 | 1 | 1 | 6 | DTDT. Young PG WAS | ||||
G/SF DET | 30 | 6 | 10 | 3 | 3 | 80.5 | 176 | SG | 141.5 | 39.5 | 0 | 1 | 6 | 2 | 17 | G DEN | ||||
F HOU | 31 | 5 | 1 | 0 | 3 | 52.75 | 122 | SF | 227.25 | 48.5 | 1 | 1 | 7 | 11 | 24 | F ORL | ||||
SG/F TOR | 29 | 2 | 4 | 1 | 1 | 48 | 153.25 | PF | 130 | 18.5 | 0 | 1 | 0 | 7 | 7 | SG/F NOP | ||||
PF/C ATL | 12 | 14 | 2 | 0 | 0 | 38.5 | 132 | C | 152.25 | 53.5 | 1 | 4 | 1 | 12 | 20 | C PHX | ||||
C CHI | 13 | 14 | 7 | 1 | 0 | 57 | 220.5 | ANY | 72.5 | 25.5 | 0 | 1 | 3 | 2 | 19 | G/SF BKN | ||||
| Total | 314.25 | 1,463.5 | 1,380.5 | 194.5 | Total | |||||||||||||||
| Optimum | 316.5 | 938.25 | 874.75 | 225.5 | Optimum | |||||||||||||||
Benched | ||||||||||||||||||||
| Pts | Reb | Ast | Stl | Blk | Blk | Stl | Ast | Reb | Pts | |||||||||||
G/SF OKC | — | 117.5 | BN | 71.75 | 16 | 0 | 1 | 1 | 4 | 10 | G/SF ORL | |||||||||
DTDK. Leonard F LAC | — | 109.25 | BN | 31 | — | F MIL | ||||||||||||||
F SAS | — | 21.5 | BN | 71 | — | SG/F MIA | ||||||||||||||
DTDJ. Kuminga F GSW | — | 134.5 | BN | 105.25 | — | DTDK. George SG/F WAS | ||||||||||||||
C LAL | 17 | 10 | 3 | 0 | 1 | 39.75 | 78.5 | BN | 46.25 | — | OUTK. Ware C MIA | |||||||||
PF/C GSW | — | 80 | BN | 118.5 | 40 | 1 | 3 | 3 | 6 | 18 | PF/C MEM | |||||||||
| Total | 39.75 | 159.75 | 105.5 | 56 | Total | |||||||||||||||
Injured Reserve | ||||||||||||||||||||
| Pts | Reb | Ast | Stl | Blk | Blk | Stl | Ast | Reb | Pts | |||||||||||
SG MIA | — | — | IR | — | — | SG/F PHI | ||||||||||||||